Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Shareholding Pattern

NSE: AAREYDRUGS • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 39.06%
FII Holding 3.86%
DII Holding 0.00%
Public Holding 45.40%
Total Shareholders 14,063
As of Dec 2025
View the latest shareholding pattern of Aarey Drugs & Pharmaceuticals (AAREYDRUGS) including promoter, FII, DII, and public holdings. Track AAREYDRUGS ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See AAREYDRUGS company valuation)

Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Shareholding Summary

  • Promoters have decreased holding from 44.80% to 39.06% in Dec 2025
  • FII/FPI have increased holdings from 1.13% to 3.86% in Dec 2025
  • DII holding remains unchanged at 0.00% in Dec 2025
  • Institutional investors have increased holdings from 1.13% to 3.86% in Dec 2025
  • Public holding has decreased from 47.01% to 45.40% in Dec 2025
  • Number of shareholders decreased from 14,897 to 14,063 in Dec 2025

AAREYDRUGS Quarterly Ownership Changes

Quarter-over-quarter changes for Aarey Drugs & Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
-5.74%
FII Holding Change
Sept 2025 to Dec 2025
+2.73%
DII Holding Change
Sept 2025 to Dec 2025
No Change
Public Holding Change
Sept 2025 to Dec 2025
-1.61%

Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Quarterly Shareholding Trends

Visual breakdown of AAREYDRUGS ownership distribution over time. Learn more about AAREYDRUGS value investing.

Promoter
FII
DII
Public
Government

Rising institutional holdings in AAREYDRUGS often correlate with improved fundamentals. Check out AAREYDRUGS income statement.

Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Shareholding Data

Download complete AAREYDRUGS ownership data for offline analysis. Discover Aarey Drugs & Pharmaceuticals P/E valuation.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 39.06% 3.86% 0.00% 0.00% 45.40% 11.69% 100.01% 14,063
Sept 2025 44.80% 1.13% 0.00% 0.00% 47.01% 7.06% 100.00% 14,897
Jun 2025 44.80% 1.97% 0.00% 0.00% 46.60% 6.63% 100.00% 15,796
Mar 2025 44.80% 2.34% 0.00% 0.00% 45.79% 7.07% 100.00% 16,257
Dec 2024 44.80% 2.34% 0.00% 0.00% 44.87% 7.99% 100.00% 16,288
Sept 2024 45.44% 2.75% 0.00% 0.00% 47.56% 4.25% 100.00% 16,676
Jun 2024 45.28% 3.40% 0.00% 0.00% 44.51% 6.82% 100.01% 16,179
Mar 2024 45.28% 3.40% 0.00% 0.00% 47.14% 4.18% 100.00% 16,821
Dec 2023 50.04% 0.00% 0.00% 0.00% 41.14% 8.82% 100.00% 15,269
Sept 2023 50.04% 0.00% 0.00% 0.00% 40.61% 9.35% 100.00% 16,086
Jun 2023 50.04% 0.00% 0.00% 0.00% 42.15% 7.81% 100.00% 17,538
Mar 2023 50.04% 0.00% 0.00% 0.00% 42.24% 7.72% 100.00% 17,699
Dec 2022 50.03% 0.00% 0.00% 0.00% 42.41% 7.55% 99.99% 17,785
Sept 2022 50.03% 0.00% 0.00% 0.00% 42.25% 7.71% 99.99% 17,649
Jun 2022 50.03% 0.00% 0.00% 0.00% 42.48% 7.48% 99.99% 17,777
Mar 2022 48.06% 0.00% 0.00% 0.00% 43.30% 8.63% 99.99% 17,565
Dec 2021 48.05% 0.00% 0.00% 0.00% 42.23% 9.72% 100.00% 13,658
Nov 2021 48.05% 0.00% 0.00% 0.00% 42.40% 9.54% 99.99% 13,150
Sept 2021 49.38% 0.00% 0.00% 0.00% 40.44% 10.18% 100.00% 13,158
Jul 2021 49.38% 0.00% 0.00% 0.00% 40.14% 10.47% 99.99% 13,731
Jun 2021 49.38% 0.00% 0.00% 0.00% 40.16% 10.46% 100.00% 12,828
Mar 2021 49.38% 0.00% 0.00% 0.00% 37.15% 13.46% 99.99% 10,688

AAREYDRUGS promoter holding above 50% indicates strong insider confidence. Explore the AAREYDRUGS share price history for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 39.06% 3.86% 0.00% 0.00% 45.40% 11.69% 100.01% 14,063
Sept 2025 44.80% 1.13% 0.00% 0.00% 47.01% 7.06% 100.00% 14,897
Jun 2025 44.80% 1.97% 0.00% 0.00% 46.60% 6.63% 100.00% 15,796
Mar 2025 44.80% 2.34% 0.00% 0.00% 45.79% 7.07% 100.00% 16,257
Dec 2024 44.80% 2.34% 0.00% 0.00% 44.87% 7.99% 100.00% 16,288
Sept 2024 45.44% 2.75% 0.00% 0.00% 47.56% 4.25% 100.00% 16,676
Jun 2024 45.28% 3.40% 0.00% 0.00% 44.51% 6.82% 100.01% 16,179
Mar 2024 45.28% 3.40% 0.00% 0.00% 47.14% 4.18% 100.00% 16,821
Dec 2023 50.04% 0.00% 0.00% 0.00% 41.14% 8.82% 100.00% 15,269
Sept 2023 50.04% 0.00% 0.00% 0.00% 40.61% 9.35% 100.00% 16,086
Jun 2023 50.04% 0.00% 0.00% 0.00% 42.15% 7.81% 100.00% 17,538
Mar 2023 50.04% 0.00% 0.00% 0.00% 42.24% 7.72% 100.00% 17,699

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 39.06% 3.86% 0.00% 0.00% 45.40% 11.69% 100.01% 14,063
Dec 2024 44.80% 2.34% 0.00% 0.00% 44.87% 7.99% 100.00% 16,288
Dec 2023 50.04% 0.00% 0.00% 0.00% 41.14% 8.82% 100.00% 15,269
Dec 2022 50.03% 0.00% 0.00% 0.00% 42.41% 7.55% 99.99% 17,785
Dec 2021 48.05% 0.00% 0.00% 0.00% 42.23% 9.72% 100.00% 13,658

Year-over-year trends reveal long-term ownership shifts.

Understanding Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Shareholding Pattern

Aarey Drugs & Pharmaceuticals shareholding pattern reveals who owns AAREYDRUGS stock and how ownership changes over time. High promoter stakes in AAREYDRUGS often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your AAREYDRUGS trades. AAREYDRUGS 52-week high low

Combine AAREYDRUGS ownership analysis with price movements and financial performance for a complete investment picture. (See Aarey Drugs & Pharmaceuticals dividend policy)